SCHEMBL6992219

SCHEMBL6992219

O=C(NO)c1c(F)cccc1F

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CES2 O00748 2/20 0.58
CES1 P23141 2/20 0.58
KMT2A Q03164 2/20 0.57
MEN1 O00255 1/20 0.57
HDAC1 Q13547 1/20 0.55
HDAC6 Q9UBN7 1/20 0.55
JAK2 O60674 1/20 0.53
JAK1 P23458 1/20 0.53
TYK2 P29597 1/20 0.53
HTT P42858 1/20 0.53
NOD2 Q9HC29 1/20 0.53
RAB9A P51151 2/20 0.50
NPC1 O15118 1/20 0.50
LMNA P02545 2/20 0.49
GAA P10253 3/20 0.46
ITGB2 P05107 1/20 0.46
ICAM1 P05362 1/20 0.46
ITGAL P20701 1/20 0.46
ALDH1A1 P00352 1/20 0.46
HPGD P15428 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL619724 0.87 CES2 (0.50) CES2CES1KMT2AMEN1HDAC1
SCHEMBL28869679 0.86 GAA (0.65) KMT2AJAK2JAK1TYK2RAB9A
SCHEMBL31259499 0.83 CES2 (0.61) CES2CES1KMT2AMEN1JAK2
SCHEMBL8372493 0.83 CES2 (0.61) CES2CES1KMT2AMEN1JAK2
SCHEMBL6989383 0.81 KMT2A (0.59) KMT2AMEN1HDAC1HDAC6RAB9A
SCHEMBL1127907 0.79 CES2 (0.56) CES2CES1KMT2AMEN1JAK2
SCHEMBL4145186 0.79 GAA (0.61) CES2CES1KMT2AMEN1JAK2
SCHEMBL23808915 0.77 KMT2A (0.63) CES2CES1KMT2AMEN1JAK2
SCHEMBL28740064 0.77 CES2 (0.54) CES2CES1KMT2AMEN1JAK2
SCHEMBL11099551 0.77 CES2 (0.54) CES2CES1KMT2AMEN1JAK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115093377-B Haloalkyl-containing 1,2, 4-oxadiazole derivative and preparation method and application thereof 贵州大学 2023-04-07 CN disclosed
CN-115093377-A Haloalkyl-containing 1,2, 4-oxadiazole derivative and preparation method and application thereof 贵州大学 2022-09-23 CN disclosed
EP-0779281-B1 ISOXAZOLES SANKYO CO (JP) 2003-10-29 EP disclosed
CN-1098843-C Isoxazoles SANKYO CO (JP) 2003-01-15 CN disclosed
US-6096771-A ISOXAZOLE DERIVATIVES EXHIBITING EXCELLENT TYPE B AND TYPE A MONOAMINE OXIDASE INHIBITORY ACTIVITIES, THEREFORE USEFUL FOR PREVENTING PARKINSON'S DISEASE, DEPRESSION AND ALZHEIMER'S DISEASE SANKYO COMPANY, LIMITED (JP) 2000-08-01 US disclosed
US-5965591-A MONOAMINE OXIDASE INHIBITOR; FOR PROPHYLAXIS AND TREATING PARKINSON'S DISEASE, DEPRESSION AND ALZHEIMER'S DISEASE SANKYO COMPANY, LIMITED (JP) 1999-10-12 US disclosed
CN-1162957-A Isoxazole derivatives SANKYO CO (JP) 1997-10-22 CN disclosed
EP-0779281-A1 ISOXAZOLES SANKYO COMPANY LIMITED (JP) 1997-06-18 EP disclosed